AmeriFlex Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

AmeriFlex Group’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8K	Hold	291	–	–	0.01%	631
2026 Q1	$25.2K	Hold	291	–	–	0.01%	563
2025 Q4	$24.7K	Sell	291 -291	-50%	-$23.2K	0.01%	555
2025 Q3	$42.2K	Buy	582 +291	+100%	+$20.1K	0.02%	484
2025 Q2	$19.2K	Hold	291	–	–	0.01%	580
2025 Q1	$20.5K	Hold	291	–	–	0.01%	685
2024 Q4	$20.2K	Buy	+291	New	+$20K	0.01%	621

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

AmeriFlex Group's IHE Position: Q2 2026 in Review

AmeriFlex Group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 291 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #631.

AmeriFlex Group first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. The position peaked at $42.2K in Q3 2025. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

AmeriFlex Group held 291 shares of iShares US Pharmaceuticals ETF worth $28.8K as of Q2 2026.
AmeriFlex Group left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up 0.01% of AmeriFlex Group's portfolio in Q2 2026, its #631 holding.
AmeriFlex Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
AmeriFlex Group's iShares US Pharmaceuticals ETF position peaked at $42.2K in Q3 2025.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.